KBC Group’s Immunogen Inc IMGN Stock Holding History

KBC Group’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-4,734	Closed	-$140K	–	1901
2023 Q4	$140K	Hold	4,734	–	–	﹤0.01%	931
2023 Q3	$75K	Buy	+4,734	New	+$78.7K	﹤0.01%	1149
2017 Q4	–	Sell	-26,660	Closed	-$204K	–	1297
2017 Q3	$204K	Hold	26,660	–	–	﹤0.01%	1118
2017 Q2	$190K	Sell	26,660 -272,953	-91%	-$1.25M	﹤0.01%	1119
2017 Q1	$1.16M	Buy	299,613 +17,893	+6%	+$52.2K	0.01%	815
2016 Q4	$575K	Buy	281,720 +63,415	+29%	+$127K	0.01%	1003
2016 Q3	$585K	Buy	+218,305	New	+$635K	0.01%	917

Other funds holding IMGN

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

KBC Group's IMGN Position: Q1 2024 in Review

KBC Group sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 4,734 shares — an estimated $140K sold.

KBC Group first reported a position in IMGN in Q3 2016 and held it in 7 quarters. The position peaked at $1.16M in Q1 2017. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

KBC Group reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
KBC Group sold 4,734 Immunogen Inc shares in Q1 2024, an estimated $140K.
KBC Group first reported a position in Immunogen Inc in Q3 2016 and held it in 7 quarters.
KBC Group's Immunogen Inc position peaked at $1.16M in Q1 2017.
3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on KBC Group's 13F filing for Q1 2024, filed 8 May 2024.